» Articles » PMID: 34578039

Evaluating the Anticarcinogenic Activity of Surface Modified/Functionalized Nanochitosan: The Emerging Trends and Endeavors

Overview
Publisher MDPI
Date 2021 Sep 28
PMID 34578039
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Chitosan begins its humble journey from marine food shell wastes and ends up as a versatile nutraceutical. This review focuses on briefly discussing the antioxidant activity of chitosan and retrospecting the accomplishments of chitosan nanoparticles as an anticarcinogen. The various modified/functionalized/encapsulated chitosan nanoparticles and nanoforms have been listed and their biomedical deliverables presented. The anticancer accomplishments of chitosan and its modified composites have been reviewed and presented. The future of surface modified chitosan and the lacunae in the current research focus have been discussed as future perspective. This review puts forth the urge to expand the scientific curiosity towards attempting a variety of functionalization and surface modifications to chitosan. There are few well known modifications and functionalization that benefit biomedical applications that have been proven for other systems. Being a biodegradable, biocompatible polymer, chitosan-based nanomaterials are an attractive option for medical applications. Therefore, maximizing expansion of its bioactive properties are explored. The need for applying the ideal functionalization that will significantly promote the anticancer contributions of chitosan nanomaterials has also been stressed.

Citing Articles

Advances in bio-polymer coatings for probiotic microencapsulation: chitosan and beyond for enhanced stability and controlled release.

Edo G, Mafe A, Razooqi N, Umelo E, Gaaz T, Isoje E Des Monomers Polym. 2025; 28(1):1-34.

PMID: 39777298 PMC: 11703421. DOI: 10.1080/15685551.2024.2448122.


A Comprehensive Compilation of Graphene/Fullerene Polymer Nanocomposites for Electrochemical Energy Storage.

Gopal J, Muthu M, Sivanesan I Polymers (Basel). 2023; 15(3).

PMID: 36772001 PMC: 9920128. DOI: 10.3390/polym15030701.


Fabrication and assessment of potent anticancer nanoconjugates from chitosan nanoparticles, curcumin, and eugenol.

El-Sherbiny M, Elekhtiar R, El-Hefnawy M, Mahrous H, Alhayyani S, Al-Goul S Front Bioeng Biotechnol. 2022; 10:1030936.

PMID: 36568301 PMC: 9773392. DOI: 10.3389/fbioe.2022.1030936.

References
1.
Park B, Kim M . Applications of chitin and its derivatives in biological medicine. Int J Mol Sci. 2011; 11(12):5152-64. PMC: 3100826. DOI: 10.3390/ijms11125152. View

2.
Hwang H, Kim I, Kwon I, Kim Y . Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release. 2008; 128(1):23-31. DOI: 10.1016/j.jconrel.2008.02.003. View

3.
Adhikari H, Nath Yadav P . Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action. Int J Biomater. 2019; 2018:2952085. PMC: 6332982. DOI: 10.1155/2018/2952085. View

4.
Ramirez K, Wahid R, Richardson C, Bargatze R, El-Kamary S, Sztein M . Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers. Clin Immunol. 2012; 144(2):98-108. DOI: 10.1016/j.clim.2012.05.006. View

5.
Belabassi Y, Moreau J, Gheran V, Henoumont C, Robert A, Callewaert M . Synthesis and Characterization of PEGylated and Fluorinated Chitosans: Application to the Synthesis of Targeted Nanoparticles for Drug Delivery. Biomacromolecules. 2017; 18(9):2756-2766. DOI: 10.1021/acs.biomac.7b00668. View